Showing 1211-1220 of 4264 results for "".
New Products/New in My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-otc-8/23455/Getting a Head Start on Skin Cancer
https://practicaldermatology.com/topics/practice-management/getting-a-head-start-on-skin-cancer/23422/A new app documents monthly skin changes to support early identification of suspicious lesions.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-21/23421/Physician Spotlight: Bruce H. Thiers, MD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-bruce-h-thiers-md-faad/23407/Mentorship Matters: Set the Pace for Long-term Success
https://practicaldermatology.com/topics/practice-management/mentorship-matters-set-the-pace-for-long-term-success/23406/Mentoring is one free strategy to building a better team. Here’s how a small but busy practice builds and develops its team and community through mentoring.Pediatric Dermatology in 2020 and Beyond
https://practicaldermatology.com/topics/pediatric/pediatric-dermatology-in-2020-and-beyond/23403/While the subspecialty has grown, there is still a personnel shortage. Here’s an update on the field.Acute Generalized Exanthematous Pustulosis
https://practicaldermatology.com/topics/other-dermatology/acute-generalized-exanthematous-pustulosis/23387/A case presentation and review of the literature.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-16/23328/In the Pipeline: What to Know About Tapinarof
https://practicaldermatology.com/topics/psoriasis/in-the-pipeline-what-to-know-about-tapinarof/23320/Here’s a closer look at the novel topical being studied for psoriasis and atopic dermatitis.CBD in the Holistic Practice of Dermatology
https://practicaldermatology.com/topics/psoriasis/cbd-in-the-holistic-practice-of-dermatology/23319/A growing body evidence suggests CBD may help with common symptoms of dermatologic diseases. Here’s what we know so far.